These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8370239

  • 1. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.
    Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM.
    Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239
    [Abstract] [Full Text] [Related]

  • 2. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
    Ullman B, Lindvall K, Lundberg JM, Sigurdsson A, Swedberg K.
    Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743
    [Abstract] [Full Text] [Related]

  • 3. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
    Feng QP, Hedner T, Andersson B, Lundberg JM, Waagstein F.
    Br Heart J; 1994 Mar; 71(3):261-7. PubMed ID: 8142196
    [Abstract] [Full Text] [Related]

  • 4. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL, Comoy E, Merlet P, Benvenuti C, Carville C, Hittinger L, Macquin-Mavier I, Bohuon C, Castaigne A.
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [Abstract] [Full Text] [Related]

  • 5. [Level of neuropeptide Y in serum of patients with chronic congestive heart failure].
    Halawa B.
    Pol Arch Med Wewn; 1996 May; 95(5):427-32. PubMed ID: 8848410
    [Abstract] [Full Text] [Related]

  • 6. Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure.
    Derchi G, Dupuis J, de Champlain J, Rouleau JL.
    Eur Heart J; 1993 Jan; 14(1):34-9. PubMed ID: 8432288
    [Abstract] [Full Text] [Related]

  • 7. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
    Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B.
    Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
    [Abstract] [Full Text] [Related]

  • 8. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man.
    Ullman B, Franco-Cereceda A, Hulting J, Lundberg JM, Sollevi A.
    J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235
    [Abstract] [Full Text] [Related]

  • 9. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
    Rudehill A, Lundberg JM, Sollevi A, Hjemdahl P.
    Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia.
    Kaijser L, Pernow J, Berglund B, Lundberg JM.
    Clin Physiol; 1990 Mar; 10(2):179-88. PubMed ID: 2318028
    [Abstract] [Full Text] [Related]

  • 11. Elevation of plasma neuropeptide Y levels in congestive heart failure.
    Maisel AS, Scott NA, Motulsky HJ, Michel MC, Boublik JH, Rivier JE, Ziegler M, Allen RS, Brown MR.
    Am J Med; 1989 Jan; 86(1):43-8. PubMed ID: 2910096
    [Abstract] [Full Text] [Related]

  • 12. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J, Lundberg JM, Kaijser L.
    J Cardiovasc Pharmacol; 1988 Jan; 12(5):593-9. PubMed ID: 2468060
    [Abstract] [Full Text] [Related]

  • 13. Neuropeptide Y and sympathetic vascular control in man.
    Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B.
    Regul Pept; 1985 Dec; 13(1):41-52. PubMed ID: 3841402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.
    Edvinsson L, Ekman R, Thulin T.
    Regul Pept; 1991 Feb 26; 32(3):279-87. PubMed ID: 1866472
    [Abstract] [Full Text] [Related]

  • 20. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
    Pernow J, Lundberg JM, Kaijser L.
    Life Sci; 1987 Jan 05; 40(1):47-54. PubMed ID: 3796213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.